REPORT ID 4208

EMEA (Europe, Middle East and Africa) Receptor Tyrosine Protein Kinase Targeted Drugs Market Report 2017

Publish Date
15-Dec-17
Pages
112
Format
Electronic (PDF)

In this report, the EMEA Receptor Tyrosine Protein Kinase Targeted Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Receptor Tyrosine Protein Kinase Targeted Drugs for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Receptor Tyrosine Protein Kinase Targeted Drugs market competition by top manufacturers/players, with Receptor Tyrosine Protein Kinase Targeted Drugs sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Aslan Pharmaceuticals Pte Ltd
    Boehringer Ingelheim GmbH
    GamaMabs Pharma SA
    Hanmi Pharmaceuticals Co Ltd
    Jiangsu Kanion Pharmaceutical Co Ltd
    Minerva Neurosciences Inc
    Pfizer Inc
    Puma Biotechnology Inc
    Shanghai Fosun Pharmaceutical (Group) Co Ltd
    XuanZhu Pharma Co Ltd
    Zensun (Shanghai) Sci & Tech Co Ltd

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Afatinib Dimaleate
    Dacomitinib
    Neratinib
    Neucardin
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Oncology
    Cardiovascular
    Central Nervous System
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Receptor Tyrosine Protein Kinase Targeted Drugs Market Report 2017
1 Receptor Tyrosine Protein Kinase Targeted Drugs Overview
    1.1 Product Overview and Scope of Receptor Tyrosine Protein Kinase Targeted Drugs
    1.2 Classification of Receptor Tyrosine Protein Kinase Targeted Drugs
        1.2.1 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Afatinib Dimaleate
        1.2.4 Dacomitinib
        1.2.5 Neratinib
        1.2.6 Neucardin
        1.2.7 Others
    1.3 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Market by Application/End Users
        1.3.1 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Oncology
        1.3.3 Cardiovascular
        1.3.4 Central Nervous System
        1.3.5 Others
    1.4 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Market by Region
        1.4.1 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Receptor Tyrosine Protein Kinase Targeted Drugs (2012-2022)
        1.5.1 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2022)

2 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Market Competition by Players/Manufacturers
        2.1.1 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sale Price by Players (2012-2017)
    2.2 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs (Volume and Value) by Type/Product Category
        2.2.1 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sale Price by Type (2012-2017)
    2.3 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs (Volume) by Application
    2.4 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs (Volume and Value) by Region
        2.4.1 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Price by Region (2012-2017)

3 Europe Receptor Tyrosine Protein Kinase Targeted Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Value (2012-2017)
        3.1.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2017)
    3.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Type
    3.3 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Application
    3.4 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume by Countries (2012-2017)
        3.4.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries (2012-2017)
        3.4.3 Germany Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
        3.4.4 France Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
        3.4.5 UK Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
        3.4.6 Russia Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
        3.4.7 Italy Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)

4 Middle East Receptor Tyrosine Protein Kinase Targeted Drugs (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Value (2012-2017)
        4.1.1 Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2017)
    4.2 Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Type
    4.3 Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Application
    4.4 Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
        4.4.4 Israel Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
        4.4.5 UAE Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
        4.4.6 Iran Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)

5 Africa Receptor Tyrosine Protein Kinase Targeted Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Value (2012-2017)
        5.1.1 Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2017)
    5.2 Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Type
    5.3 Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Application
    5.4 Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume by Countries (2012-2017)
        5.4.2 Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries (2012-2017)
        5.4.3 South Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)

6 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturers/Players Profiles and Sales Data
    6.1 Aslan Pharmaceuticals Pte Ltd
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Boehringer Ingelheim GmbH
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 GamaMabs Pharma SA
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Hanmi Pharmaceuticals Co Ltd
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Jiangsu Kanion Pharmaceutical Co Ltd
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Minerva Neurosciences Inc
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Pfizer Inc
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Puma Biotechnology Inc
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Shanghai Fosun Pharmaceutical (Group) Co Ltd
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 XuanZhu Pharma Co Ltd
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Zensun (Shanghai) Sci & Tech Co Ltd

7 Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Cost Analysis
    7.1 Receptor Tyrosine Protein Kinase Targeted Drugs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Receptor Tyrosine Protein Kinase Targeted Drugs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Receptor Tyrosine Protein Kinase Targeted Drugs Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast (2017-2022)
    11.1 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Price and Trend Forecast (2017-2022)
    11.2 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Receptor Tyrosine Protein K